Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Pain Management
        Popular Press
        Preventive Medicine
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Weekly Messages E-mail
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
etanercept  etanercept
hypertension  hypertension
chf  chf
antiphospholipid  antiphospholipid
fibrosis  fibrosis
mrsa  mrsa
scid  scid
renal cell  renal cell
rickets  rickets
counterpulsation  counterpulsation
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women
Nordin BEC – Study demonstrates that calcium supplementation of about 1,000 mg daily has a significant preventive effect on bone loss in postmenopausal women for at least 4 years.

Methods
  • A review of literature to estimate the effect of calcium supplementation in postmenopausal women
  • 32 trials of calcium supplementation in 3,169 postmenopausal women were reviewed
  • 24 publications reporting 32 controlled trials lasting at least 1 year were found
  • They provided annual percentage changes in bone mass or density at one or more sites in the calcium-treated and control subjects

Results
  • Median calcium supplement: 1,000 mg; median duration of trials: 2 yrs; total number of sites measured: 79
  • Average of the mean rates of change in bone mass or density:
    • -1.07% p.a. in the controls and
    • -0.27% p.a. (ns) in the treated subjects
  • Effect of calcium was much the same at all measured sites (forearm/hand, proximal femur, spine, and total body and others)
  • Supplements of <700 mg were not effective, but there was no significant beneficial effect of higher doses
  • A faster bone loss at total calcium intakes below 1,150 mg than on intakes over 1,350 mg was noted
  • Effect of calcium appeared to be lost after 4 yrs of treatment
[more...]
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

General Internal Medical Articles: Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.